|
HS Code |
758513 |
| Chemical Name | 7,8-Dihydroxyflavone |
| Synonyms | Tropoflavin |
| Molecular Formula | C15H10O4 |
| Molar Mass | 254.24 g/mol |
| Cas Number | 38183-03-8 |
| Appearance | Yellow crystalline powder |
| Melting Point | 257-259°C |
| Solubility | Slightly soluble in water; soluble in DMSO and ethanol |
| Structure Type | Flavone derivative |
| Iupac Name | 7,8-dihydroxy-2-phenylchromen-4-one |
| Pubchem Cid | 5281607 |
| Logp | 2.2 |
| Storage Conditions | Store at 2-8°C, protect from light |
As an accredited 7,8-Dihydroxyflavone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 7,8-Dihydroxyflavone is packaged in a 1 gram amber glass vial with a tamper-evident cap and clear labeling. |
| Shipping | 7,8-Dihydroxyflavone is shipped in secure, airtight containers, typically under ambient conditions. The packaging ensures protection from light, moisture, and contamination. Standard shipping regulations for non-hazardous chemicals apply, with proper labeling and documentation. Expedited or temperature-controlled shipping options are available upon request to maintain product quality during transit. |
| Storage | 7,8-Dihydroxyflavone should be stored in a tightly sealed container, protected from light and moisture. It is best kept at -20°C, away from sources of heat and incompatible materials. Store in a well-ventilated, dry area, and avoid excessive exposure to air to prevent degradation. Always follow appropriate laboratory safety protocols when handling and storing this chemical. |
Applications of 7,8-Dihydroxyflavone in Industrial Manufacturing7,8-Dihydroxyflavone is a research-backed flavonoid with highly specific industrial uses, primarily in advanced pharmaceutical formulations, nutraceutical development, cosmetic manufacturing, veterinary pharmaceuticals, and functional beverage concentrates. As a manufacturer, we supply this ingredient in compliance with strict quality and traceability systems, serving production chains that demand validated performance and detailed regulatory alignment. 1. Central Nervous System Active Pharmaceutical Ingredient (API) IntermediateIn the pharmaceutical sector, 7,8-Dihydroxyflavone serves as an API intermediate in the production of investigational and specialty drugs targeting neurodegenerative and neuropsychiatric disorders. Its BDNF-mimetic properties have led to its inclusion in advanced CNS research compound development, especially for novel therapies addressing cognitive impairment and brain trauma. Downstream processors introduce this compound during small-molecule synthesis phases, with formulation adjustments closely monitored to balance therapeutic index and stability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Nutraceutical Active Ingredient for Cognitive Health SupplementsWithin the nutraceutical industry, manufacturers select this flavone for brain-support complex formulations targeting adult cognitive maintenance and memory support. Quality demands involve ingredient identity verification and standardization to regulatory-accepted purity. Processors generally add the material post-extraction enrichment, with blending controlled for homogeneous distribution before encapsulation or powder filling for bulk supply. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Cosmetic Ingredient for Dermal FormulationsCosmetic manufacturers use 7,8-Dihydroxyflavone in skin care formulas focused on antioxidative defense and anti-aging actives. It addresses oxidative stress pathways and assists with visible signs of skin fatigue in high-performance serums, essence concentrates, and premium facial masks. The ingredient integrates post-base emulsion formation to ensure compound integrity, followed by microfiltration prior to final product filling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Medicine Formulations for Companion AnimalsLeading veterinary pharmaceutical producers employ 7,8-Dihydroxyflavone for experimental neuroprotective and cognitive supplements tailored to companion animals, primarily in health-maintenance supplements for aging pets or those under neurological observation. Facilities maintain ingredient traceability according to veterinary medicinal product regulations. It enters the downstream flow after premix preparation, and undergoes thorough content uniformity checks before being formulated as palatable animal-friendly forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Ingredient in Functional Beverage ConcentratesProducers of functional beverage premixes incorporate this flavonoid to enhance focus and support neurological well-being in high-value drinkable blends. Compliance with local additive and novel ingredient rules is mandatory, with inclusion levels reflecting both efficacy research and flavor matrix compatibility. The material is solubilized in aqueous phases during concentrate preparation, then pasteurized or cold-processed according to product style and packaging requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 7,8-Dihydroxyflavone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 7,8-Dihydroxyflavone always pulls our attention back to science’s roots and how it shapes the materials we work with each day. The chemical itself is a synthetic flavonoid, once only a concept in academic research—now found at the heart of studies on neuroprotection and biochemical signaling. We have spent years refining each step in the manufacture of this compound. Our approach focuses on repeatability, crystallization quality, batch purity, and yield control, because researchers, formulation teams, and industrial customers rely on a consistent material baseline to actually drive their work forward.
7,8-Dihydroxyflavone stands apart from ordinary flavonoids. The backbone structure looks simple under the microscope—two hydroxyl groups on the flavone scaffold—but this fine difference gives it specialized properties. For us, the recognition did not come from reading a paper or a review. Our experience in the lab and from customer feedback showed that any impurity, no matter how minor, quickly reduced its utility in pharmacological research and fine chemical synthesis. We built on that knowledge. Each batch now matches strict appearance criteria: a pale yellow to off-white solid, highly sensitive to moisture and light, so we keep storage and packaging under stringent control.
Early on in production, we learned that maintaining the right ambient temperatures during crystallization preserves not just yield but also the precise distribution of particulate sizes in our lots. Uncontrolled humidity meant clumping, loss of performance, waste, and customer complaints about dissolution inconsistencies. We responded by sealing off production lines, investing in climate regulation, and designing all finishing steps for repeatability. These lessons came with cost and labor, but the payback arrived quickly: users started reporting much better solubility in DMSO and ethanol. Our chemists record melting ranges each batch—usually between 255 and 257°C—because these tiny differences indicate what’s happening at the molecular level.
Some customers ask why we list HPLC or NMR data on our certs, or why we publish trace metal content levels and solvent residue analyses. Through direct experience, we found that material described as 98% pure on paper could show pronounced assay differences when re-tested by spectrometry. This led us away from simply posting a single “purity” figure. Now every batch we ship carries detailed spectral, elemental, and residual data. It keeps development on track for our customers who rely on 7,8-Dihydroxyflavone in vivo and in vitro systems, especially those looking for fine differences in phosphorylation or receptor-binding studies. For us, transparency isn’t an abstract guideline. It’s embedded in each analytic run, each shipment.
Handling 7,8-Dihydroxyflavone demands a measured approach. The dust presents a fine inhalation hazard, much like similar polyphenolic compounds. In processing, we mandated fume capture hoods, double-glove handling, and enclosed blending on every shift, after workers experienced mild but repeated respiratory irritation during scale-up trials. Light exposure can trigger slow yellowing, so turning off overhead lighting and employing amber glass became standard. These methods rarely get discussed in distant regulatory documents, but in daily operations, such measures keep product integrity and worker safety aligned.
7,8-Dihydroxyflavone attracts interest from brain research labs, antibody development teams, and assay designers. Its track record as a selective TrkB agonist draws far more inquiry than generic flavonoid benchmarks. We field questions from small biotech groups about dose-response variability in neuronal cell lines, from academic researchers seeking reliable standards for synaptic plasticity work, and from pharmaceutical partners building on animal models. Every inquiry reminds us that the compound serves as both a research tool and a potential therapeutic benchmark. Challenges in reproducibility often stem from minuscule batch differences in polymorph content or trace hydration. These issues carry real downstream consequences for those who run sensitive behavioral or biochemical assays. Recognizing these needs, we keep our quality assurance feedback loop active long after a batch leaves our facility.
Generic flavones might look similar on the shelf, yet key distinctions separate 7,8-Dihydroxyflavone from its cousins. For example, quercetin or luteolin, both more widely available, show much weaker selectivity in neurotrophin receptor binding. Our customers have observed that those compounds often produce ambiguous results in TrkB receptor-based screens. 7,8-Dihydroxyflavone, on the other hand, allows researchers to reach repeatable outcomes, thanks to its well-characterized pharmacology. In manufacturing, we see how tightly these distinctions matter—minute differences in purity or hydration state show up rapidly in functional readouts, far more than with less selective flavonoids.
Few outside the supply chain realize how sourcing and reaction design affect compound purity and price stability. We purchase raw intermediates in granular form, because powder grades arrive with more tightly bound moisture, complicating the initial hydroxylation. Scaling up sometimes risks heat buildup, so we segment each run based on thermal feedback data. Reaction times vary with each shipment of starting material. By logging every variable, our teams stay ready for adjustments. These hands-on practices sound utilitarian, but they save customers from unexplained batch failures, save us re-work costs, and uphold trust in our supply over repeat cycles.
Some potential customers ask about solvent residues, especially those using in neural cell work. Rather than maintaining an industry minimum, we take extra steps with rinse cycles to reduce DMF or DMSO traces well below reported regulatory thresholds. We stock newer columns for scale-up HPLC cleanups, and we maintain our own tanks for deionized water flushing rather than outsourcing that care. These steps mean extra labor and extra oversight, but we see outcomes first-hand. Fewer support tickets arrive from batch-to-batch assay drift; more references cite our source in peer-reviewed publications. That kind of feedback never comes from third parties, only from direct accounts by those running experiments at the bench.
7,8-Dihydroxyflavone’s stability hinges on moisture and light. In early years, product left our hands in standard white HDPE bottles, and complaints emerged about discoloration and crystallinity loss after only a few weeks in basic laboratory storage. We responded by switching to amber glass vials with lyophilization-grade stoppers. We now vacuum-seal all bulk product while working with temperature-controlled couriers for international deliveries. These decisions grew out of support calls and direct stability data, not marketing ambitions. We noted how prolonged shelf life and consistent powder flow allow formulation teams to skip laborious reprocessing. For long-term users, this practical improvement matters more than a glossy label—reliable material translates to fewer delays and less troubleshooting for every order shipped.
Reproducibility sits at the foundation of scientific progress. From our side, consistency in 7,8-Dihydroxyflavone production does not happen through luck or broad-spectrum filtration. Our teams perform multi-stage recrystallizations with detailed settling time and solvent composition logs. We turn to lower temperature washes in the final cycle to eliminate subvisible residues. Each tweak followed production setbacks—batches running out of spec, customers calling in with questions, and our own QC staff recording off-hours for retests. These iterations shaped an operation where deviation triggers immediate review, root cause analysis, and corrective steps before new batches roll out.
Our analytical chemists back up these physical procedures by running advanced proton and carbon NMR for structure confirmation. Optical rotation and mass spec results get posted for every lot, not just as a courtesy but because clear data on batch-to-batch uniformity gives partners confidence while developing protocols. We use fresh calibration standards for each batch, and when deviations arise we initiate direct customer notifications. This approach builds dependability, as users can rely on the data without resorting to their own expensive retesting each shipment.
Across research sectors, 7,8-Dihydroxyflavone forms the backbone of innovation in pathways sensitive to oxidative damage, synaptic loss, and signaling cascades subject to glutamate-induced toxicity. Beyond TrkB studies, formulation scientists explore its potential in small-molecule libraries, cosmetic grade additives, and even environmental studies for antioxidant benchmarking. Our experiences with diverse applications give us unique insights. Users from academia alert us when project timelines depend on expedited shipping and last-minute reordering, while pharma partners depend on long-view stability for biobanking or IP development. Every sector prioritizes reproducibility, but each carries special challenges.
We watch closely for news on clinical leads and animal trials incorporating the product. Some customers publish open data sets with pharmacokinetics and metabolism data, while others quietly use our material in preliminary screens. Both share practical insights with us. Researchers in the behavioral neuroscience field, for instance, detailed how even small shifts in moisture content changed compound performance in aquatic maze models. These observations sent us tweaking desiccant choices and changing our pre-loading procedures, thus reducing variability in future orders.
Maintaining a reliable supply chain for a specialty chemical such as 7,8-Dihydroxyflavone means collaborating with users, not just supplying a raw material. Many customer pain points reach our desk through direct calls or study citations—chromatographic drift, unexpected byproducts, or shipping delays all push us to respond with adaptations. We have invested in logistics partnerships that allow customs-compliant paperwork for regulated destinations and streamlined reordering platforms for university system buyers. Sometimes a single phone call identifies a gap in batch labeling or opens a new line of reporting that leads to improved packaging for all outbound orders.
We share preliminary characterization reports with academic labs on request, so that project leaders can tailor their approach before making larger commitments. Manufacturing small, high-purity flavonoids often sounds routine, but real-world feedback continues to inform every aspect of our practice—from raw materials screening to the label on each bottle. No amount of corporate optimism substitutes for results seen under the customer’s microscope or in a journal’s published data set.
Every time a tank fills with a new batch of 7,8-Dihydroxyflavone, we pull samples, calibrate instruments, and look for the same telltale markers each round. Errors rarely hide; they show up in color, in melting points, in spectra just slightly off baseline. We do not treat these as annoyances but as signposts for where attention must turn next. Over months and years, each lesson absorbed from a failed assay, a bottle returned, or a trial delayed builds durability into our operation.
We remind our team and customers that the reason this product creates such broad research impact lies in these manufacturing details—not simply in chemical theory but in dedicated, disciplined, hands-on refinement. As new research directions emerge and regulatory expectations shift, we adapt only after evidence from the lab and the loading dock converge. That is the path we follow because long-term credibility in specialty chemicals never rests on a single lot or certificate. It comes from showing up at every step, from sourcing to shipment, and from listening when the science points to new solutions.